Clinical Trials Browser

Recruiting × Interventional × Denosumab × Clear all

NCT06513624 2025-07-25

ETC-159-02

Phase 1 Recruiting

With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer

NCT06749886 2024-12-27

An Exploratory Study of Tislelizumab in Combination with Chemotherapy in Immuno-experienced Patients with EGFR/ALK/ROS1-negative Advanced NSCLC in the Second-line Setting

Phase 2 Recruiting

Lung Neoplasms